ICU中脓毒症-1与脓毒症-3的临床评价
该研究基于MIMIC-III数据库,纳入21,491例感染患者,比较脓毒症-1(SIRS≥2条)与脓毒症-3(SOFA评分≥2)标准在ICU入院第一天的应用及以全因死亡为终点的结局。符合脓毒症-1的患者中13.42%不符合脓毒症-3,其21天死亡率为6.96%;符合脓毒症-3的患者中7.00%不符合脓毒症-1,其21天死亡率为10.76%。排除既往慢性器官功能障碍后,脓毒症-1中18.41%不符合脓毒症-3(21天死亡率6.39%),脓毒症-3中6.00%不符合脓毒症-1(21天死亡率9.11%)。在无既往慢性器官功能障碍的感染患者中,SIRS≥2条或SOFA≥2预测21天全因死亡的敏感性分别为96.0%和91.0%。作者认为脓毒症-3标准缩小了脓毒症人群但牺牲了敏感性,假阴性可能延误诊断。
要点
- 符合脓毒症-1但不符合脓毒症-3的患者占13.42%,其21天死亡率为6.96%,提示脓毒症-3可能漏诊部分高危患者。
- 符合脓毒症-3但不符合脓毒症-1的患者占7.00%,其21天死亡率为10.76%。
- 排除既往慢性器官功能障碍后,脓毒症-1中18.41%不符合脓毒症-3(21天死亡率6.39%),脓毒症-3中6.00%不符合脓毒症-1(21天死亡率9.11%)。
- 在无既往慢性器官功能障碍的感染患者中,SIRS≥2条预测21天全因死亡的敏感性为96.0%,SOFA≥2为91.0%。
- SOFA评分反映病情严重程度,而SIRS评分反映临床明显的宿主对感染的反应。
适用人群与场景
- 从MIMIC-III数据库中选取的ICU入院第一天符合感染且满足脓毒症-1(SIRS≥2条)或脓毒症-3(SOFA评分≥2)标准的患者,共21,491例。
- 亚组分析基于既往慢性器官功能障碍状态进行分层。
诊断标准与关键阈值
- 脓毒症-1:感染且满足两条或以上全身炎症反应综合征(SIRS)标准。
- 脓毒症-3:感染且序贯器官衰竭评估(SOFA)评分≥2分。
研究设计与关键结果
- 研究类型为基于MIMIC-III数据库的回顾性队列分析,纳入21,491例感染患者,比较脓毒症-1与脓毒症-3标准,主要终点为全因死亡。
- 符合脓毒症-1的患者中13.42%不符合脓毒症-3,该人群21天死亡率为6.96%;符合脓毒症-3的患者中7.00%不符合脓毒症-1,21天死亡率为10.76%。
- 排除既往慢性器官功能障碍后,脓毒症-1中18.41%不符合脓毒症-3(21天死亡率6.39%),脓毒症-3中6.00%不符合脓毒症-1(21天死亡率9.11%)。
- 在无既往慢性器官功能障碍的感染患者中,SIRS≥2条或SOFA≥2预测21天全因死亡的敏感性分别为96.0%和91.0%。
- SOFA和SIRS的受试者工作特征曲线下面积均可用于预测死亡,但SOFA评分反映病情严重程度,SIRS评分反映临床明显的宿主对感染的反应。
证据类型、等级与局限
- 证据类型:基于MIMIC-III数据库的回顾性队列分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为脓毒症-3诊断标准缩小了脓毒症人群但牺牲了敏感性,由此产生的假阴性可能延误疾病诊断。
- 作者认为当脓毒症-3已定义时,比较SIRS与SOFA标准的预测性能可能是不合适的。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: There has been considerable controversy between sepsis-1 and sepsis-3 criteria.
METHODS: Patients with infection meeting two or more systemic inflammatory response syndrome (SIRS) criteria (sepsis-1) or a Sequential Organ Failure Assessment (SOFA) score ≥ 2 (sepsis-3) on the first day after ICU admission were selected from the Medical Information Mart for Intensive Care-III database, and their outcomes were compared using all-cause death as the end point. Subgroup analysis was also performed based on prior chronic organ dysfunction.
RESULTS: There were 21,491 infected patients included. Of those meeting the diagnostic criteria for sepsis-1, 13.42% did not satisfy sepsis-3 criteria, and this population had a 21-day mortality rate of 6.96%. In contrast, 7.00% of the patients meeting sepsis-3 criteria did not meet sepsis-1 criteria, and their 21-day mortality rate was 10.76%. When excluding preexisting organ conditions, 18.41% of patients with sepsis-1 did not meet sepsis-3 criteria, with a 21-day mortality rate of 6.39%, and 6.00% of patients with sepsis-3 did not meet sepsis-1 criteria, with a 21-day mortality rate of 9.11%. When two or more SIRS criteria or SOFA score ≥ 2 were applied to predict 21-day all-cause mortality in infected patients without prior chronic organ dysfunction, the sensitivity was 96.0% or 91.0%, respectively. Although the areas under the receiver operator curve of both SOFA and SIRS criteria could be used for predicting mortality, SOFA score represented the severity of the condition, whereas SIRS score represented a clinically evident host response to infection.
CONCLUSIONS: Sepsis-3 diagnostic criteria narrow the sepsis population at the expense of sensitivity, and the resulting false negatives may delay disease diagnosis. It may be inappropriate to compare the prediction performance of SIRS and SOFA criteria when sepsis-3 is defined.
参考来源
- Fang X, Wang Z, Yang J, et al. Clinical Evaluation of Sepsis-1 and Sepsis-3 in the ICU. Chest. 2017. PMID: 28711593. doi:10.1016/j.chest.2017.06.037
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。